Shorts

Morning Coffee and Updates: ASCP & Deprescribing

Asking Questions About Irritability in Mood Disorders

Psychedelics as Disease-Modifying Therapy

Evolution of Ketamine-Assisted Psychotherapy

Looking Forward to New Data at ASCP

The Outpatient Future of Consultation-Liaison Psychiatry

Morning Coffee and Updates: New Plan to Protect Youth Online

The Need For Quick Initiation of OUD and PTSD Treatment

Checking In With Older Adult Patients About Sexual Wellness

Future of Psychedelics and Brain Stimulation

Potential of CTX-1301 for ADHD

Spotting Digital Behavioral Addiction

Talking About Sexual Wellness With Older Adult Patients

Looking Out for Childbirth-Related PTSD

Brain Health: Neuroscience & Resilience

Assessing the Prodromal Period in Schizophrenia

Managing Bipolar Disorder & Medication During Pregnancy

Treating Psychosis in Dementia With Zervimesine

FDA Decision Date Extended for SQ Leqembi for Alzheimer Treatment

Paying Attention to When Deprescribing is Needed

The Deprescribing Conversation: Focusing on Patient Needs

TMS for Postpartum Depression

Antidepressants in 3rd Trimester Pregnancy

Improving Sleep Behaviors for Youth ADHD

The Myth of Monodiagnosis & Prescribing Off-Label

A New Era for Alzheimer Agitation Treatment With Auvelity

Synaptic Regrowth: A Breakthrough for Schizophrenia

GLP-1s & Plasticity: How Insulin Affects the Brain

Morning Coffee and Updates: The Executive Order on Psychedelics

New Monoclonal Antibodies: Remternetug for Alzheimer Disease